Your browser doesn't support javascript.
loading
Systematic identification of trans eQTLs as putative drivers of known disease associations.
Westra, Harm-Jan; Peters, Marjolein J; Esko, Tõnu; Yaghootkar, Hanieh; Schurmann, Claudia; Kettunen, Johannes; Christiansen, Mark W; Fairfax, Benjamin P; Schramm, Katharina; Powell, Joseph E; Zhernakova, Alexandra; Zhernakova, Daria V; Veldink, Jan H; Van den Berg, Leonard H; Karjalainen, Juha; Withoff, Sebo; Uitterlinden, André G; Hofman, Albert; Rivadeneira, Fernando; Hoen, Peter A C 't; Reinmaa, Eva; Fischer, Krista; Nelis, Mari; Milani, Lili; Melzer, David; Ferrucci, Luigi; Singleton, Andrew B; Hernandez, Dena G; Nalls, Michael A; Homuth, Georg; Nauck, Matthias; Radke, Dörte; Völker, Uwe; Perola, Markus; Salomaa, Veikko; Brody, Jennifer; Suchy-Dicey, Astrid; Gharib, Sina A; Enquobahrie, Daniel A; Lumley, Thomas; Montgomery, Grant W; Makino, Seiko; Prokisch, Holger; Herder, Christian; Roden, Michael; Grallert, Harald; Meitinger, Thomas; Strauch, Konstantin; Li, Yang; Jansen, Ritsert C.
Afiliação
  • Westra HJ; Department of Genetics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, the Netherlands.
  • Peters MJ; Department of Internal Medicine, Erasmus Medical Centre Rotterdam, the Netherlands.
  • Esko T; The Netherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging (NGI-NCHA), Leiden/Rotterdam, the Netherlands.
  • Yaghootkar H; Estonian Genome Center, University of Tartu, Riia 23b, 51010, Tartu, Estonia.
  • Schurmann C; Genetics of Complex Traits, University of Exeter Medical School, Exeter, EX1 2LU, UK.
  • Kettunen J; Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, D-17487 Greifswald, Germany.
  • Christiansen MW; Institute for Molecular Medicine Finland FIMM, FI-00014 University of Helsinki, Helsinki, Finland.
  • Fairfax BP; Department of Chronic Disease Prevention, National Institute for Health and Welfare, FI-00271 Helsinki, Finland.
  • Schramm K; Cardiovascular Health Research Unit, University of Washington, Seattle, WA.
  • Powell JE; Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Zhernakova A; Department of Oncology, Cancer and Haematology Centre, Churchill Hospital, Oxford, OX3 7LJ.
  • Zhernakova DV; Institute of Human Genetics, Helmholz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
  • Veldink JH; Institute of Human Genetics, Technical University Munich, Munich, Germany.
  • Van den Berg LH; University of Queensland Diamantina Institute, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Karjalainen J; The Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.
  • Withoff S; Department of Genetics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, the Netherlands.
  • Uitterlinden AG; Department of Genetics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, the Netherlands.
  • Hofman A; Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Rivadeneira F; Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Hoen PAC'; Department of Genetics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, the Netherlands.
  • Reinmaa E; Department of Genetics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, the Netherlands.
  • Fischer K; Department of Internal Medicine, Erasmus Medical Centre Rotterdam, the Netherlands.
  • Nelis M; The Netherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging (NGI-NCHA), Leiden/Rotterdam, the Netherlands.
  • Milani L; Department of Epidemiology, Erasmus Medical Center Rotterdam, the Netherlands.
  • Melzer D; The Netherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging (NGI-NCHA), Leiden/Rotterdam, the Netherlands.
  • Ferrucci L; Department of Epidemiology, Erasmus Medical Center Rotterdam, the Netherlands.
  • Singleton AB; Department of Internal Medicine, Erasmus Medical Centre Rotterdam, the Netherlands.
  • Hernandez DG; The Netherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging (NGI-NCHA), Leiden/Rotterdam, the Netherlands.
  • Nalls MA; Department of Epidemiology, Erasmus Medical Center Rotterdam, the Netherlands.
  • Homuth G; Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Nauck M; Estonian Genome Center, University of Tartu, Riia 23b, 51010, Tartu, Estonia.
  • Radke D; Estonian Genome Center, University of Tartu, Riia 23b, 51010, Tartu, Estonia.
  • Völker U; Estonian Genome Center, University of Tartu, Riia 23b, 51010, Tartu, Estonia.
  • Perola M; Estonian Genome Center, University of Tartu, Riia 23b, 51010, Tartu, Estonia.
  • Salomaa V; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Barrack Road, Exeter, EX2 5DW, UK.
  • Brody J; Clinical Research Branch, National Institute on Aging NIA-ASTRA Unit, Harbor Hospital, MD, USA.
  • Suchy-Dicey A; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 35 Lincoln Drive, Bethesda, MD, USA.
  • Gharib SA; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 35 Lincoln Drive, Bethesda, MD, USA.
  • Enquobahrie DA; Department of Molecular Neuroscience and Reta Lila Laboratories, Institute of Neurology, UCL, Queen Square House, Queen Square, London WC1N 3BG, UK.
  • Lumley T; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 35 Lincoln Drive, Bethesda, MD, USA.
  • Montgomery GW; Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, D-17487 Greifswald, Germany.
  • Makino S; Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, D-17475 Greifswald, Germany.
  • Prokisch H; Institute for Community Medicine, University Medicine Greifswald, D-17487 Greifswald, Germany.
  • Herder C; Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, D-17487 Greifswald, Germany.
  • Roden M; Estonian Genome Center, University of Tartu, Riia 23b, 51010, Tartu, Estonia.
  • Grallert H; Department of Chronic Disease Prevention, National Institute for Health and Welfare, FI-00271 Helsinki, Finland.
  • Meitinger T; Department of Chronic Disease Prevention, National Institute for Health and Welfare, FI-00271 Helsinki, Finland.
  • Strauch K; Cardiovascular Health Research Unit, University of Washington, Seattle, WA.
  • Li Y; Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • Jansen RC; Computational Medicine Core, Center for Lung Biology, Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
Nat Genet ; 45(10): 1238-1243, 2013 Oct.
Article em En | MEDLINE | ID: mdl-24013639
ABSTRACT
Identifying the downstream effects of disease-associated SNPs is challenging. To help overcome this problem, we performed expression quantitative trait locus (eQTL) meta-analysis in non-transformed peripheral blood samples from 5,311 individuals with replication in 2,775 individuals. We identified and replicated trans eQTLs for 233 SNPs (reflecting 103 independent loci) that were previously associated with complex traits at genome-wide significance. Some of these SNPs affect multiple genes in trans that are known to be altered in individuals with disease rs4917014, previously associated with systemic lupus erythematosus (SLE), altered gene expression of C1QB and five type I interferon response genes, both hallmarks of SLE. DeepSAGE RNA sequencing showed that rs4917014 strongly alters the 3' UTR levels of IKZF1 in cis, and chromatin immunoprecipitation and sequencing analysis of the trans-regulated genes implicated IKZF1 as the causal gene. Variants associated with cholesterol metabolism and type 1 diabetes showed similar phenomena, indicating that large-scale eQTL mapping provides insight into the downstream effects of many trait-associated variants.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Locos de Características Quantitativas Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2013 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Locos de Características Quantitativas Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2013 Tipo de documento: Article